GlycoRNAs first burst onto the molecular biology scene in 2021, when researchers reported that small RNAs can be decorated with N-glycans and displayed on the surfaces of living cells. That discovery overturned the long-standing assumption that glycosylation, the attachment of sugar chains, was an exclusive feature of proteins and lipids processed through the secretory pathway. Subsequent work has linked surface glycoRNAs to processes such as neutrophil recruitment, and imaging methods such as ARPLA have allowed researchers to visualize them in single cells. Yet the functions of glycoRNAs, particularly those exported from cells on EVs, have remained largely unexplored. The new study addresses this gap by systematically profiling the glycoRNA content of different vesicle subtypes and asking whether those molecules matter for vesicle function.

Central to the research is a chemical biology strategy based on metabolic labeling. The team used bioorthogonal handles, chemical tags that can be introduced into glycans inside living cells without perturbing native biochemistry, to mark glycoRNAs as they are synthesized. Because these azide-bearing tags react selectively with complementary probes, the researchers could selectively enrich, detect, and sequence glycoRNAs associated with EVs, separating them from the sea of unmodified RNAs that dominate vesicle cargo. This approach, combined with an EV-focused proximity assay the authors call EV-CAP, allowed sensitive detection of glycoRNAs on individual vesicles and produced the most expansive catalog to date of the extracellular vesicle glycoRNA landscape.

With that toolkit in hand, the researchers examined how glycoRNA profiles differ across vesicle types, cell types, and even culture conditions. They found that large EVs carry glycoRNA repertoires that vary with the producing cell type and with the passage number of the cells, meaning the vesicle glycoRNA fingerprint shifts as cells age in culture. In experiments with colon cancer cell lines, specific glycoRNA species such as those derived from small nucleolar RNAs, including SNORD1B and U2, could be detected on large EVs, and machine-learning-style dimensionality reduction by t-distributed stochastic neighbor embedding separated cell lines based purely on their vesicle glycoRNA fluorescence signatures. Notably, a single lEV glycoRNA species achieved strong discrimination between non-tumor colon cells and colon cancer cells, suggesting diagnostic potential.

The study also documented dynamic changes in vesicle glycoRNA content over time. In SW620 colon cancer cells grown through successive passages, the signals of U8 and U2 glycoRNAs on large EVs decreased as passage number increased, whereas SNORA21 glycoRNA signal rose. This passage-dependence indicates that glycoRNA trafficking onto vesicles tracks the physiological state of the producing cell, supporting the idea that EV glycoRNAs could serve as biomarkers of cell state. Small EVs, meanwhile, displayed glycoRNA profiles distinct from those of their large vesicle counterparts, pointing to vesicle-specific sorting mechanisms that determine which glycoRNAs are loaded into which parcels.

Functionally, the researchers demonstrated that EVs deliver their glycoRNAs into recipient cells, and that glycoRNAs subsequently appear in EVs secreted by those recipient cells. Using a clever double-labeling scheme, the team distinguished where these second-generation glycoRNAs came from. Donor EV glycans carried azide tags detectable with one fluorescent probe, while newly synthesized RNAs in the recipient cells were labeled with 4-thiouridine and visualized with a second chemistry. Förster resonance energy transfer signals, which report when two fluorophores sit within nanometers of each other, revealed that some recipient-cell EV glycoRNA signals arise from glycoRNAs made fresh by the recipient cell, while others trace back to material inherited from the donor vesicles. GlycoRNA transport, in other words, is bidirectional and involves both new synthesis and cargo recycling.

Perhaps the most striking finding concerns regulation of EV uptake itself. When the researchers pre-hybridized EV-associated glycoRNAs with sequence-specific complementary DNA probes targeting species such as SNORA67, SNORD104, or SNORA21, uptake of the vesicles by recipient cells dropped dramatically. Control experiments with non-complementary DNA, or with vesicles from cells in which the corresponding small nucleolar RNAs had been knocked down, reinforced the specificity and importance of the effect. The blockade was observed in both MDA-MB-231 breast cancer cells and MCF-7 cells, and the team showed that the hybridization strategy altered vesicle surface properties as measured by zeta potential. Importantly, an endocytosis inhibitor, genistein, also reduced EV-mediated glycoRNA transport, linking the process to vesicle internalization pathways.

These results reframe glycoRNAs as actionable control points in vesicle biology. Because blocking specific glycoRNA species can heavily reduce EV uptake, the molecules behave as determinants of vesicle tropism, the propensity of vesicles to enter particular cell types. That opens the door to engineering vesicles with altered glycoRNA compositions to improve targeted drug delivery, or conversely, to intercepting pathological vesicle communication, for example in cancer, where EVs are known to promote metastasis and immune evasion. The parallels with glycan biology are notable: just as vesicle surface glycans have been exploited as cancer biomarkers, vesicle glycoRNAs may encode information about the producing cell that both recipients and diagnosticians can read.

The study also comes with important technical caveats and resources for the community. Sequencing data have been deposited in the Gene Expression Omnibus under accession GSE297960, and molecular dynamics simulation data are available through Zenodo, giving other labs the raw material to interrogate the glycoRNA landscape independently. Detection assays relied on careful controls, including western blot characterization of vesicle preparations and quantitative comparisons across biological replicates, and the authors note that glycoRNA functions on cell surfaces remain largely unexplored beyond these initial observations. As the field moves forward, questions about how glycoRNAs are synthesized, sorted onto vesicles, and recognized by recipient cells will demand attention. For now, the message is clear: the sugar-coated RNAs riding on extracellular vesicles are both messengers and gatekeepers, and learning their language may prove essential for decoding, and eventually directing, the conversation between cells.

Subject of Research: Glycosylated RNA cargo and function in extracellular vesicle-mediated intercellular communication

Article Title: Profiling extracellular vesicle glycoRNAs defines their function in vesicular communication

Article References: Chen, X., Hao, C., Chen, X., Chen, T., Xiao, W., Zhu, J., Zhang, J., Zhang, Y., Chen, M., Lin, H., & Song, Y. (2026). Profiling extracellular vesicle glycoRNAs defines their function in vesicular communication. Nature Structural & Molecular Biology. https://doi.org/10.1038/s41594-026-01897-2

Image Credits: AI Generated

DOI: 10.1038/s41594-026-01897-2

Keywords: extracellular vesicles, glycoRNA, glycosylation, RNA modifications, intercellular communication, small nucleolar RNAs, bioorthogonal labeling, EV uptake, biomarkers, cell signalling, Profiling, extracellular